Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome

Clinical Reviews in Allergy and Immunology

Volumn 39, Issue 3, 2010, Pages 160-165

  Girardi, Guillermina ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antiphospholipid antibodies; Neutrophils; Pregnancy loss; Protease activated receptors; Tissue factor

Indexed keywords

COMPLEMENT COMPONENT C5A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN;

ANTIPHOSPHOLIPID SYNDROME; COMPLEMENT ACTIVATION; FETUS WASTAGE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PREGNANCY COMPLICATION; RECURRENT ABORTION; REVIEW; THROMBOGENESIS; THROMBOSIS; TROPHOBLAST;

EID: 78149466868     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8187-1     Document Type: Review

References (53)

1. JL Beaumont 1954 Syndrome hemorrragique acquis du a un anticoagulant circulant Sang 25 1 15 1:STN:280:DyaG2c%2Fns1Cnug%3D%3D 13156476
2. IM Nilsson B Astedt U Hedner D Berezin 1975 Intrauterine death and circulating anticoagulant ('antithromboplastin') Acta Med Scand 197 153 159 1:STN:280:DyaE2M7ktlKhtw%3D%3D 10.1111/j.0954-6820.1975.tb04897.x 1124664
3. Firkin BG, Howard MA, Radford N (1980) Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet ii:366
4. S Loizou MA Byron HJ Englert J David GV Hughes MJ Walport 1988 Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus Q J Med 68 525 531 1:STN:280:DyaL1M3pslartQ%3D%3D 3252304
5. RH Derksen PG de Groot 2008 The obstetric antiphospholipid syndrome J Reprod Immunol 77 1 41 50 1:CAS:528:DC%2BD1cXovFOktQ%3D%3D 10.1016/j.jri.2006. 12.003 17239960
6. A Tincani C Bazzani S Zingarelli A Lojacono 2008 Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment Semin Thromb Hemost 34 3 267 273 1:CAS:528:DC%2BD1MXnvF2guro%3D 10.1055/s-0028-1082270 18720306
7. Blank M, Shoenfeld Y (2009) Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clin Rev Allergy Immunol (in press)
8. DL Yetman WH Kutteh 1996 Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies Fertil Steril 66 540 546 1:STN:280: DyaK28vhtlClsg%3D%3D 8816614
9. MD Stephenson 1996 Frequency of factors associated with habitual abortion in 197 couples Fertil Steril 66 24 29 1:STN:280:DyaK283otFyitg%3D%3D 8752606
10. WA Wilson AE Gharavi T Koike MD Lockshin DW Branch JC Piette, et al. 1999 International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome Arthritis Rheum 42 1309 1311 1:STN:280:DyaK1MzjtVSmsg%3D%3D 10.1002/1529-0131(199907)42:7<1309::AID- ANR1>3.0.CO;2-F 10403256 (Pubitemid 30265586)
11. MD Lockshin LS Sammaritano SS Schwartzman 2000 Validation of the Sapporo criteria for antiphospholipid antibody syndrome Arthritis Rheum 43 440 443 1:STN:280:DC%2BD3c7lsFGmsQ%3D%3D 10.1002/1529-0131(200002)43:2<440::AID- ANR26>3.0.CO;2-N 10693886 (Pubitemid 30395755)
12. WH Kutteh 1996 Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone Am J Obstet Gynecol 174 1584 1589 1:CAS:528:DyaK28XjvFyhtbg%3D 10.1016/S0002-9378(96)70610-5 9065133 (Pubitemid 26165282)
13. R Rai H Cohen M Dave L Regan 1997 Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies J Brit Med 314 253 257 1:STN:280: DyaK2s7nsVyhtQ%3D%3D (Pubitemid 27047378)
14. Y Zhang T Deng M Luther, et al. 1994 Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice J Clin Invest 94 1320 1327 1:CAS:528:DyaK2cXlslKnsbc%3D 10.1172/JCI117451 7521887
15. SJ Soifer KG Peters J O'Keefe SR Coughlin 1994 Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development Am J Pathol 144 60 69 1:CAS:528:DyaK2cXis1Kmurk%3D 8291612
16. TH Bugge Q Xiao KW Kombrinck, et al. 1996 Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation Proc Natl Acad Sci USA 93 6258 6263 1:CAS:528:DyaK28XjvFejt74%3D 10.1073/pnas.93.13.6258 8692802 (Pubitemid 26230292)
17. GC Parry JH Erlich P Carmeliet T Luther N Mackman 1998 Low levels of tissue factor are compatible with development and hemostasis in mice J Clin Invest 101 560 569 1:CAS:528:DyaK1cXosVagtA%3D%3D 10.1172/JCI814 9449688
18. P Carmeliet N Mackman L Moons, et al. 1996 Role of tissue factor in embryonic blood vessel development Nature 383 73 75 1:CAS:528:DyaK28XlsV2jsbo%3D 10.1038/383073a0 8779717 (Pubitemid 26296462)
19. B Osterud T Flæstad 1983 Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosis Thromb Haemost 49 5 7 1:STN:280:DyaL3s7pvVeitA%3D%3D 6845273
20. RL Edwards FR Rickles M Cronlund 1981 Abnormalities of blood coagulation in patients with cancer J Lab Clin Med 98 917 928 1:STN:280: DyaL38%2Fns1OrsQ%3D%3D 7310230
21. E Leatham P Bath J Tooze A Camm 1995 Increased monocyte tissue factor expression in coronary disease Br Heart J 73 10 13 1:STN:280: DyaK2M7psVOmtg%3D%3D 10.1136/hrt.73.1.10 7888247
22. DM Monroe NS Key 2007 The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking J Thromb Haemost 5 1097 1105 1:CAS:528:DC%2BD2sXntl2ksL0%3D 10.1111/j.1538-7836.2007.02435.x 17567444 (Pubitemid 46902106)
23. E Camerer W Huang SR Coughlin 2000 Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa Proc Natl Acad Sci USA 97 5255 5260 1:CAS:528:DC%2BD3cXjsVWntLY%3D 10.1073/pnas.97.10.5255 10805786 (Pubitemid 30313705)
24. W Ruf A Dorfleutner M Riewald 2003 Specificity of coagulation factor signaling J Thromb Haemost 1 1495 1503 1:CAS:528:DC%2BD2cXktFOjsbk%3D 10.1046/j.1538-7836.2003.00300.x 12871285
25. BM Mueller RA Reisfeld TS Edgington W Ruf 1992 Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis Proc Natl Acad Sci USA 89 1 6 10.1073/pnas.89.24.11832 (Pubitemid 23004738)
26. MJ Cuadrado C López-Pedrera MA Khamashta, et al. 1997 Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression Arthritis Rheum 40 834 841 1:CAS:528:DyaK2sXjsV2hs7Y%3D 10.1002/art.1780400509 9153543
27. PM Dobado-Berrios C Lopez-Pedrera F Velasco MA Aguirre A Torres M Cuadrado 1999 Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome Thromb Haemost 82 1578 1582 1:CAS:528:DyaK1MXotVehsb0%3D 10613637
28. JC Reverter D Tassies J Font, et al. 1996 Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S Arterioscler Thromb Vasc Biol 16 1319 1326 1:STN:280:DyaK2s%2Fmsl2nsw%3D%3D 8911269
29. J Nojima Y Masuda Y Iwatani, et al. 2008 Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients Biochem Biophys Res Commun 365 195 200 1:CAS:528:DC%2BD2sXhtlalsL7I 10.1016/j.bbrc.2007.10.173 17986380 (Pubitemid 350102473)
30. JC Reverter D Tàssies J Font, et al. 1998 Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes Arthritis Rheum 41 1420 1427 1:CAS:528: DyaK1cXls1eisr8%3D 10.1002/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2- U 9704640 (Pubitemid 28373121)
31. O Amengual T Atsumi MA Khamashta GRV Hughes 1998 The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome Thromb Haemost 79 276 281 1:CAS:528:DyaK1cXhtVeju7Y%3D 9493575
32. H Zhou AS Walberg RAS Roubey 2004 Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep Blood 104 2353 2358 1:CAS:528:DC%2BD2cXovVegt78%3D 10.1182/blood-2004- 01-0145 15226179 (Pubitemid 39331833)
33. RA Roubey CW Pratt JP Buyon JB Winfield 1992 Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I J Clin Invest 90 1100 1104 1:CAS:528:DyaK38XlvFSjs7k%3D 10.1172/JCI115926 1522218
34. M Vega-Ostertag K Casper R Swerlick D Ferrara EN Harris SS Pierangeli 2005 Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies Arthritis Rheum 52 1545 1554 1:CAS:528:DC%2BD2MXkvFCisrg%3D 10.1002/art.21009 15880836 (Pubitemid 40663946)
35. C Lopez-Pedrera P Buendia N Barbarroja E Siendones F Velasco MJ Cuadrado 2006 Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells Clin Appl Thromb Hemost 12 41 45 1:CAS:528:DC%2BD28Xhs1ans74%3D 10.1177/107602960601200107 16444433 (Pubitemid 43221570)
36. A Kornberg Y Renaudineau M Blank P Youinou Y Sheffield 2000 Anti-beta2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells Isr Med Assoc J 2 27 31 10909414
37. ME Vega-Ostertag DE Ferrara Z Romay-Penabad, et al. 2007 Role of p38 mutagen-activated protein kinas in antiphospholipid antibodymediated thrombosis and endothelial cell activation J Thromb Haemost 5 1828 1834 1:CAS:528:DC%2BD2sXhtFahtLzF 10.1111/j.1538-7836.2007.02680.x 17723121 (Pubitemid 47288938)
38. K Ritis M Doumas D Mastellos, et al. 2006 A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways J Immunol 177 4794 4802 1:CAS:528:DC%2BD28Xps1Gns7s%3D 16982920
39. G Girardi J Berman P Redecha, et al. 2003 Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome J Clin Invest 112 1644 1654 1:CAS:528:DC%2BD3sXpslens74%3D 14660741
40. G Girardi P Redecha JE Salmon 2004 Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 1222 1226 1:CAS:528:DC%2BD2cXptVOgsbc%3D 10.1038/nm1121 15489858 (Pubitemid 39540439)
41. P Redecha R Tilley M Tencati, et al. 2007 Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury Blood 110 2423 2431 1:CAS:528:DC%2BD2sXhtFCnsbrP 10.1182/blood-2007-01-070631 17536017 (Pubitemid 47523163)
42. NW Bunnett 2006 Protease-activated receptors: how proteases signal to cells to cause inflammation and pain Semin Thromb Hemost 32 39 48 1:CAS:528:DC%2BD28XltFagtLs%3D 10.1055/s-2006-939553 16673265
43. AC Chin WY Lee A Nusrat N Vergnolle CA Parkos 2008 Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration J Immunol 181 5702 5710 1:CAS:528:DC%2BD1cXhtF2hsLzI 18832729
44. VM Shpacovitch S Seeliger M Huber-Lang, et al. 2007 Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils Exp Dermatol 16 799 806 1:CAS:528:DC%2BD2sXhtFyjur7E 10.1111/j.1600-0625.2007.00605.x 17845211 (Pubitemid 47377644)
45. P Redecha CW Franzke W Ruf N Mackman G Girardi 2008 Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome J Clin Invest 118 3453 3461 1:CAS:528:DC%2BD1cXht1ChsrjK 18802482
46. M Takemoto JK Liao 2001 Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Arterioscler Thromb Vasc Biol 21 1712 1719 1:CAS:528:DC%2BD3MXosVKntLw%3D 10.1161/hq1101.098486 11701455
47. R Rosenson C Tangney 1998 Antiatherosclerotic properties of statins JAMA 279 1643 1650 1:CAS:528:DyaK1cXjslyjsrY%3D 10.1001/jama.279.20.1643 9613915 (Pubitemid 28248591)
48. KI Paraskevas V Stathopoulos DP Mikhailidis 2007 Emerging indications for statins: a pluripotent family of agents with several potential applications Curr Pharm Des 13 3622 3636 1:CAS:528:DC%2BD1cXnsVOgsw%3D%3D 10.2174/138161207782794194 18220799 (Pubitemid 350238933)
49. SS Pierangeli DE Ferrara 2005 More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells J Thromb Haemost 3 1112 1113 1:STN:280:DC%2BD2M3jsFKmtw%3D%3D 10.1111/j.1538-7836.2005.01262.x 15869627 (Pubitemid 41632856)
50. Y Kunieda K Nakagawa H Nishimura, et al. 2003 HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells Thromb Res 110 227 234 1:CAS:528:DC%2BD3sXnsVKgsro%3D 10.1016/S0049-3848(03) 00346-3 14512087 (Pubitemid 37338298)
51. PS Pollack KE Shields DM Burnett MJ Osborne ML Cunningham ME Stepanavage 2005 Pregnancy outcomes after maternal exposure to simvastatin and lovastatin Birth Defects Res A Clin Mol Teratol 73 888 896 1:CAS:528:DC%2BD2MXht1yks7vL 10.1002/bdra.20181 16163683 (Pubitemid 41742199)
52. RJ Edison M Muenke 2005 Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins Am J Med Genet A 135 230 231
53. J Contrino G Hair DL Kreutzer FR Rickles 1996 In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease Nat Med 2 209 215 1:CAS:528:DyaK28Xps1yluw%3D%3D 10.1038/nm0296-209 8574967 (Pubitemid 26054985)